Susquehanna Fundamental Investments, LLC Axogen, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.44 - $13.09 $30,406 - $42,162	3,221 Added 15.12%	24,518 $244,000
Q3 2022 Nov 14, 2022	SELL	$8.14 - $12.25 $6,512 - $9,800	-800 Reduced 3.62%	21,297 $254,000
Q1 2022 May 16, 2022	BUY	$7.26 - $10.7 $160,424 - $236,437	22,097 New	22,097 $175,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $697M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.